Becher PM et al (2022) An update on global epidemiology in heart failure. Eur Heart J 43(32):3005–3007
Santhanakrishnan R et al (2016) Atrial fibrillation begets heart failure and vice versa: temporal associations and differences in preserved versus reduced ejection fraction. Circulation 133(5):484–492
Article PubMed PubMed Central Google Scholar
Savarese G et al (2023) Global burden of heart failure: a comprehensive and updated review of epidemiology. Cardiovasc Res 118(17):3272–3287
Kotecha D et al (2016) Heart failure with preserved ejection fraction and atrial fibrillation: vicious twins. J Am Coll Cardiol 68(20):2217–2228
Liu G et al (2021) Meta-analysis of atrial fibrillation and outcomes in patients with heart failure and preserved ejection fraction. Heart Lung Circ 30(5):698–706
Article CAS PubMed Google Scholar
Di Biase L et al (2016) Ablation versus amiodarone for treatment of persistent atrial fibrillation in patients with congestive heart failure and an implanted device. Circulation 133(17):1637–1644
Marrouche Nassir F et al (2018) Catheter ablation for atrial fibrillation with heart failure. N Engl J Med 378(5):417–427
Article CAS PubMed Google Scholar
Michael RM et al (2011) Radiofrequency ablation for persistent atrial fibrillation in patients with advanced heart failure and severe left ventricular systolic dysfunction: a randomised controlled trial. Heart 97(9):740
Prabhu S et al (2017) Catheter ablation versus medical rate control in atrial fibrillation and systolic dysfunction: the CAMERA-MRI study. J Am Coll Cardiol 70(16):1949–1961
Tzeis S et al (2024) European heart rhythm association/heart rhythm society/Asia pacific heart rhythm society/latin American heart rhythm society expert consensus statement on catheter and surgical ablation of atrial fibrillation. Europace 26(4):euae043. https://doi.org/10.1093/europace/euae043
Article PubMed PubMed Central Google Scholar
Tsang TSM et al (2002) Left ventricular diastolic dysfunction as a predictor of the first diagnosed nonvalvular atrial fibrillation in 840 elderly men and women. J Am Coll Cardiol 40(9):1636–1644
Santhanakrishnan R et al (2016) Atrial fibrillation begets heart failure and vice versa. Circulation 133(5):484–492
Article PubMed PubMed Central Google Scholar
Oraii A et al (2024) Atrial fibrillation ablation in heart failure with reduced vs preserved ejection fraction: a systematic review and meta-analysis. JAMA Cardiol 9(6):545–555. https://doi.org/10.1001/jamacardio.2024.0675
Matthew JP et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71
Mahalleh M et al (2024) Atrial Fibrillation Ablation Compared with Conventional Medical Therapies in Heart Failure With Preserved Ejection Fraction. PROSPERO 2024 CRD42024540195 Available from: https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42024540195. Accessed 13 May 2024
Gotschall T (2021) EndNote 20 desktop version. J Med Libr Assoc 109(3):520–522. https://doi.org/10.5195/jmla.2021.1260
Article PubMed PubMed Central Google Scholar
Julian PTH et al (2011) The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ 343:d5928
Sterne JAC et al (2019) RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 366:l4898. https://doi.org/10.1136/bmj.l4898
Sterne JA et al (2016) ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ 355:i4919
Article PubMed PubMed Central Google Scholar
Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22(4):719–748
Robins J, Greenland S, Breslow NE (1986) A general estimator for the variance of the Mantel-Haenszel odds ratio. Am J Epidemiol 124(5):719–723
Article CAS PubMed Google Scholar
Knapp G, Hartung J (2003) Improved tests for a random effects meta-regression with a single covariate. Stat Med 22(17):2693–2710
Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21(11):1539–1558
Cochran WG (1954) Some methods for strengthening the common χ2 tests. Bioethics 10:417
R Core Team (2021). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. URL: https://www.R-project.org/. Accessed 13 May 2024
Wickham H et al (2019) Welcome to the tidyverse. J Open Source Software 4:1686
Balduzzi S, Rücker G, Schwarzer G (2019) How to perform a meta-analysis with R: a practical tutorial. Evid Based Ment Health 22(4):153–160
Article PubMed PubMed Central Google Scholar
Parkash R et al (2022) Randomized ablation-based rhythm-control versus rate-control trial in patients with heart failure and atrial fibrillation: results from the RAFT-AF trial. Circulation 145(23):1693–1704
Article CAS PubMed Google Scholar
von Olshausen G et al (2022) Catheter ablation for patients with atrial fibrillation and heart failure: insights from the Swedish Heart Failure Registry. Eur J Heart Fail 24(9):1636–1646
Rattka M et al (2021) Catheter ablation for atrial fibrillation in HFpEF patients-a propensity-score-matched analysis. J Cardiovasc Electrophysiol 32(9):2357–2367
Tsuda T et al (2023) Effect of catheter ablation for atrial fibrillation in heart failure with mid-range or preserved ejection fraction- pooled analysis of the AF Frontier Ablation Registry and Hokuriku-Plus AF Registry. Circ J 87(7):939–946
Article CAS PubMed Google Scholar
Xie Z et al (2023) Ablation for atrial fibrillation improves the outcomes in patients with heart failure with preserved ejection fraction. Europace 26(1):euad363. https://doi.org/10.1093/europace/euad363
Article PubMed PubMed Central Google Scholar
Arora S et al (2020) Catheter ablation for atrial fibrillation in patients with concurrent heart failure. Am J Cardiol 137:45–54
Chieng D et al (2023) Atrial fibrillation ablation for heart failure with preserved ejection fraction: a randomized controlled trial. JACC Heart Fail 11(6):646–658
Article CAS PubMed Google Scholar
Packer DL et al (2021) Ablation versus drug therapy for atrial fibrillation in heart failure: results from the CABANA trial. Circulation 143(14):1377–1390
Article CAS PubMed PubMed Central Google Scholar
Huerta A et al (2016) Association of cystatin C with heart failure with preserved ejection fraction in elderly hypertensive patients: potential role of altered collagen metabolism. J Hypertens 34(1):130–138
Article CAS PubMed Google Scholar
Tsuda T, et al (2022) Effect of catheter ablation for atrial fibrillation in heart failure with mid-range or preserved ejection fraction― pooled analysis of the AF Frontier Ablation Registry and Hokuriku-Plus AF Registry ―. Circulation Journal. advpub.
Xie Z, et al (2024) Ablation for atrial fibrillation improves the outcomes in patients with heart failure with preserved ejection fraction. EP Europace. 26(1): p. euad363.
Packer DL et al (2021) Ablation versus drug therapy for atrial fibrillation in heart failure. Circulation 143(14):1377–1390
Comments (0)